Anixa Biosciences, Inc. ( ANIX) - Key Metrics
ANIX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0 | -$0.08 | -$0.05 | -$0.05 |
| 2026Q2 | $0 | -$0.08 | -$0.05 | -$0.05 |
| 2026Q1 | $0 | -$0.08 | -$0.08 | -$0.08 |
| 2025Q4 | $0 | -$0.08 | -$0.04 | -$0.04 |
| 2025Q3 | $0 | -$0.07 | -$0.05 | -$0.05 |
ANIX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -11.22 |
| 2026Q2 | 0% | -10.71 |
| 2026Q1 | 0% | -9.84 |
| 2025Q4 | 0% | -12.65 |
| 2025Q3 | 0% | -11.01 |
ANIX
Price: $2.88
52 week price:
Earnings Per Share: -0.32 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 24809
Market Capitalization: 100.4 million